IQVIA Holdings Inc. IQV | NYSE

$197.27 $5.75 | 3.00%

After Hours
$206.34 $9.07 | 4.60%

Company Overview:

Market Cap: $35.80B
PE Ratio: 25.96
52-Week Range: $187.62 - $261.73
Dividend Yield (FWD): 0.00% ($0.00)

10 Year Performance Metrics:

Total Return (with DRIP): 228.29% (12.62% / yr)
Total Return (no DRIP): 228.29% (12.62% / yr)
Share Price: 228.29%
Dividend Increase: nan%
IQV 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

IQV Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
IQV Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
IQV Price CAGR:1Y: -12.32%2Y: -1.03%5Y: 4.81%10Y: 12.57%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

IQV Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - IQV
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - IQV
14-Day FREE Trial Get Full Access Now!

IQV Earnings, Revenue, Cash & Debt, Shares Outstaning:

IQV - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
IQV - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
IQV - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
IQV - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
IQV - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
IQV - Cash & Debt
14-Day FREE Trial Get Full Access Now!
IQV - Revenue
14-Day FREE Trial Get Full Access Now!
IQV Revenue CAGR:1Y: 4.28%2Y: 4.58%5Y: 7.07%10Y: 10.78%
IQV - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
IQV EPS CAGR:1Y: -4.91%2Y: 1.99%5Y: 39.83%10Y: 8.12%
IQV - Net Income
14-Day FREE Trial Get Full Access Now!
IQV Net Income CAGR:1Y: -5.94%2Y: 0.35%5Y: 37.97%10Y: 11.89%
IQV - EBITDA
14-Day FREE Trial Get Full Access Now!
IQV EBITDA CAGR:1Y: -6.88%2Y: 5.28%5Y: 8.73%10Y: 15.46%
IQV - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
IQV Free Cash Flow CAGR:1Y: 30.66%2Y: -9.55%5Y: 25.83%10Y: 17.36%
IQV - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
IQV Free Cash Flow / Share CAGR:1Y: 31.24%2Y: -8.47%5Y: 27.50%10Y: 13.25%
IQV - Gross Profit
14-Day FREE Trial Get Full Access Now!
IQV Gross Profit CAGR:1Y: 5.19%2Y: 5.38%5Y: 8.49%10Y: 14.05%
IQV - Expenses
14-Day FREE Trial Get Full Access Now!
IQV Expenses CAGR:1Y: 2.74%2Y: -4.65%5Y: 0.13%10Y: 21.19%
IQV - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
IQV Shares Outstanding CAGR:1Y: -0.70%2Y: -1.38%5Y: -1.53%10Y: 3.50%
IQV - Share Buybacks
14-Day FREE Trial Get Full Access Now!
IQV Share Buybacks CAGR:1Y: 38.89%2Y: -2.41%5Y: -7.67%10Y: N/A
IQV - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
IQV Stock-Based Comp CAGR:1Y: 14.89%2Y: -5.91%5Y: 14.87%10Y: 23.05%
IQV - Dividends
14-Day FREE Trial Get Full Access Now!
IQV Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
IQV - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
IQV Revenue CAGR:1Y: 4.28%2Y: 4.58%5Y: 7.07%10Y: 10.78%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

IQV - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IQV Actual Revenue CAGR:1Y: 4.28%2Y: 4.58%5Y: 7.07%10Y: 10.78%
IQV - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IQV Actual EPS CAGR:1Y: -4.91%2Y: 1.99%5Y: 39.83%10Y: 8.12%
IQV - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IQV Actual Net Income CAGR:1Y: -5.94%2Y: 0.35%5Y: 37.97%10Y: 11.89%
IQV - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IQV Actual EBITDA CAGR:1Y: -6.88%2Y: 5.28%5Y: 8.73%10Y: 15.46%

Ratios, Profit Margins & Return on Capital:

IQV - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
IQV Net Profit Margin CAGR:1Y: -9.74%2Y: -3.98%5Y: 28.86%10Y: 1.01%
IQV - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
IQV Gross Profit Margin CAGR:1Y: 0.88%2Y: 0.76%5Y: 1.32%10Y: 2.96%
IQV - Price to Earnings
14-Day FREE Trial Get Full Access Now!
IQV - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
IQV - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
IQV - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

IQV Dividends Info:

Annual Dividend: $
Forward Yield: 0%
Ex-Dividend Date:
Lifetime Dividens / Share: $0.00

IQV Dividend History: Dates, Payments & Yield list

Below is a schedule of all IQV dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for IQV

Based on past 10-year performance, here are IQV growth metrics:

Share price CAGR of +12.62%
Dividend CAGR of +0%
Using IQV CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

IQV
Current Price$197.27
Start Shares50.69
Start Value$10,000
 
After 10 years:
Final Share Count50.69
Dividends Payment$0.00
Annual Dividends$0
Yield on cost0.00%
Share Price$575.03
Total Dividends$0
Final Value$29,150

Estimated Future Value + Dividends - IQV

NOTE: Above numbers are our estimate based on IQV's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

IQVIA Holdings Inc. (IQV) had its IPO on 2013-05-09, and is trader on NYSE stock exchange.

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

IQV website: https://www.iqvia.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial